News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Secora Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/17/2023 |
4
| Secora Michael (CFO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 4,727 shares
@ $9.19, valued at
$43.4k
Sold 25,000 shares
@ $9.2717, valued at
$231.8k
Sold 25,000 shares
@ $8.9007, valued at
$222.5k
Exercised 37,500 options to buy
@ $2.22, valued at
$83.3k
Exercised 37,500 options to buy
@ $2.22, valued at
$83.3k
|
|
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/15/2023 |
4
| Secora Michael (CFO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 25,000 shares
@ $9.9323, valued at
$248.3k
Sold 25,000 shares
@ $10.0735, valued at
$251.8k
Exercised 37,500 options to buy
@ $2.22, valued at
$83.3k
Exercised 37,500 options to buy
@ $2.22, valued at
$83.3k
|
|
| 05/17/2023 |
4
| Secora Michael (CFO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 4,760 shares
@ $5.6, valued at
$26.7k
|
|
| 04/28/2023 |
4/A
| Secora Michael (CFO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 58,342 shares
@ $0
Granted 1,957 shares
@ $0
Paid exercise price by delivering 678 shares
@ $11.4, valued at
$7.7k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2022 |
4
| Secora Michael (CFO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,065 shares
@ $11.86, valued at
$12.6k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|